Long term visual outcomes in ranibizumab non-responders: patients with neovascular age-related macular degeneration switched from ranibizumab to aflibercept

被引:0
|
作者
Afshar, Farid [1 ]
Fletcher, Emily [1 ]
Mohamed, Quresh [1 ]
Johnston, Rob [1 ]
机构
[1] Cheltenham Gen Hosp, Ophthalmol, Eastleigh, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
520
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Twelve-month outcomes of aflibercept versus ranibizumab for neovascular age-related macular degeneration (AMD)
    Almuhtaseb, Hussein
    Michaels, Luke
    Vardarinos, Thanos
    Lotery, Andrew J.
    EYE, 2018, 32 (11) : 8 - 10
  • [42] Non-Responders to Intravitreal Ranibizumab in Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    OPHTHALMIC RESEARCH, 2017, 57 (01) : 42 - 47
  • [43] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Jae Hui Kim
    Jong Woo Kim
    Chul Gu Kim
    Dong Won Lee
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1677 - 1685
  • [44] Long-term outcomes of intravitreal aflibercept in neovascular age-related macular degeneration with pigment epithelial detachments refractory to ranibizumab and bevacizumab
    Huo, Siya
    Chau, Felix Yan-Fay
    Lim, Jennifer I.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [45] Long-term switching between ranibizumab and aflibercept in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    Lee, Dong Won
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1677 - 1685
  • [46] Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
    Griffin, David R.
    Richmond, Preston P.
    Olson, John C.
    JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [47] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab
    Unsal, Erkan
    Cubuk, Mehmet Ozgur
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (04): : 337 - 342
  • [49] Non-responders to multiple ranibizumab injections in treatment of exudative age-related macular degeneration and the effect of the switch treatment to aflibercept.
    Manethova, Katerina
    Ernest, Jan
    Nemec, Pavel
    Rejmont, Leos
    Folleco, Fredy Manolo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [50] OUTCOMES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN GREECE UNDER RANIBIZUMAB
    Yfantopoulos, J.
    Rouvas, A.
    Chatzaras, A.
    Xanthopoulou, P.
    Theodosiadis, P.
    VALUE IN HEALTH, 2014, 17 (07) : A604 - A604